Content
Tekmira Pharmaceuticals Shares Soar 57% After Merger Agreement With OnCore Biopharma
Article By:
Terry Chrisomalis
Read
Tuesday, January 13, 2015 11:55 AM EDT
Oncore Biopharma to become wholly-owned subsidiary of Tekmira after the transaction completes.
In this article: TKMR
HCA Previews 2014 Results
Article By:
Business Wire
Read
Sunday, January 11, 2015 10:32 AM EDT
HCA Holdings, Inc. announced that it expects its Adjusted EBITDA to exceed its previously issued guidance range of $7.25 to $7.35 billion for 2014
In this article: HCA
NRX Received Positive Scientific Advice For Phase 3 Program In Diabetic Nephropathy
Article By:
BioMedReports
Read
Friday, January 9, 2015 5:13 PM EDT
NRX has announced that the Company has received positive Scientific Advice from the European Medicines Agency (EMA) regarding their Phase 3 program with Pyridorin® in diabetic nephropathy.
In this article: NRX
TalkMarkets, A New Financial News Site, Announces It Is Breaking Records
Article By:
Melanie Felsman
Read
Wednesday, January 7, 2015 12:39 AM EDT
TalkMarkets, the first new financial-information website to reach critical mass in recent years, just celebrated a milestone.
Isis Pharmaceuticals Soars 10% After RNA Drug Collaboration Deal With J&J
Article By:
Terry Chrisomalis
Read
Monday, January 5, 2015 6:12 PM EDT
According to the deal, both companies will co-develop RNA drugs targeting autoimmune diseases of the GI tract.
Cerus Corporation Jumps Following Clinical Update
Article By:
BioMedReports
Read
Monday, January 5, 2015 4:44 PM EDT
Cerus Corporation shares jumped 4% after the company announced that the haemoglobin content (53.1g) of INTERCEPT content treated red blood cell components (RBCs).
In this article: CERS
Graco Announces 4 Acquisitions To Drive Long-Term Growth In The Company’s Industrial Products Segment
Article By:
Business Wire
Read
Saturday, January 3, 2015 4:42 PM EDT
Acquisitions expand Graco’s global footprint and industries served.
In this article: GGG
Tekla Healthcare Opportunities Fund Pays Distribution
Article By:
Business Wire
Read
Saturday, January 3, 2015 2:25 PM EDT
It is currently estimated that this distribution is derived from short-term capital gains.
In this article: THQ
PTC Therapeutics, Inc. Commenced A Rolling Submission Of A New Drug Application
Article By:
BioMedReports
Read
Wednesday, December 24, 2014 11:55 AM EDT
Translarna is intended to treat nonsense Duchenne muscular dystrophy.
In this article: PTCT
Abbvie Wins FDA Approval For Hepatitis C Drug; What Does This Mean For Gilead Sciences?
Article By:
Terry Chrisomalis
Read
Monday, December 22, 2014 7:18 PM EDT
Abbvie Wins FDA Approval For Hepatitis C and Scores Exclusive deal with Express Scripts
Apple Pay Is Now Compatible With 90% Of The Credit Cards Americans Use
Article By:
Shelly Palmer
Read
Tuesday, December 16, 2014 2:56 PM EDT
Today, Apple announced that in recent weeks the company had signed up dozens more banks, retail stores and start-ups to adopt Apple Pay, the company’s new e-commerce product, which allows customers to buy things with little more than a wave of their iPhone.
In this article: AAPL
Arrowhead Announces IND Filing To Begin Two Trials For Hepatitis B
Article By:
Terry Chrisomalis
Read
Tuesday, December 16, 2014 2:48 PM EDT
(ARWR) jumped 10% today, after the news that the company has filed an IND to the FDA to begin testing two phase 2b trials using its drug ARC-520 in patients with the Hepatitis B virus.
The First Issue Of FIMENA EXPO 2015 - Forex & Investment Mena Expo 2015
Article By:
Street Smart Event Management
Read
Monday, December 15, 2014 9:30 AM EDT
Taking investments and online trading to the next level, this is where it all happens…
Merck Achieves Initial Positive Results In A Phase 1 Study For Breast Cancer
Article By:
Terry Chrisomalis
Read
Thursday, December 11, 2014 10:02 PM EDT
Merck achieves early success using KEYTRUDA in breast cancer
In this article: MRK
Shares Of Bluebird Bio Surge 60% At Market Open On Positive Results Against Rare Blood Disease
Article By:
Terry Chrisomalis
Read
Tuesday, December 9, 2014 1:41 PM EDT
Bluebird bio achieves early success in providing gene therapy to chronic blood transfusion patients.